ÄϹ¬NG28¼¯ÍÅ

½Ó´ý»á¼ûÄϹ¬NG28¼¯ÍÅÉÌѧԺ£¡

98777
Ä¿½ñλÖÃ: Ê×Ò³ > µ³½¨Ö®Éù > ¾¯Ê¾½ÌÓý > ÕýÎÄ

¾¯Ê¾½ÌÓý

20¶àÃû¸ßУְԱѧÊõ²»¶Ë±»×ª´ï£¡ÉæÉúÒâÂÛÎÄ¡¢ØâÇÔµÈ

ʱ¼ä£º£º2025-06-14 13:03:58  ×÷Õߣº£ºÈËÃñÈÕ±¨  ÉóºËÈË£º£ºÈËÃñÈÕ±¨  ±à¼­£º£ºÈËÃñÈÕ±¨  ÈªÔ´£º£º¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»áÍøÕ¾    µã»÷£º£º ´Î

½üÆÚ£¬£¬¾­¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á¼àÊÓίԱ»áÊÓ²ìÉóÒ飬£¬Óɹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»áίÎñ¾Û»áÉ󶨣¬£¬¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á¶ÔÏà¹Ø¿ÆÑв»¶Ë°¸¼þÉæÊÂÖ÷Ìå¾ÙÐÐÁË´¦Àí¡£ÏÖÆ¾Ö¤Óйػ®¶¨£¬£¬½«¸øÓèת´ïÆ·ÆÀµÄÔðÈÎÖ÷ÌåÐû²¼ÈçÏ£º£º

£¨Ò»£©¾­²é£¬£¬¹ãÎ÷ij¸ßУº£ºØ¾ÛÁ¼µÈ½ÒÏþµÄÂÛÎÄ¡°Juliang He#, et al. Long noncoding RNA CCDC144NL-AS1 promotes the oncogenicity of osteosarcoma by acting as a molecular sponge for microRNA-490-3p and thereby increasing HMGA2 expression. OncoTargets and Therapy, 2021, 14:1-13.¡±±£´æÉúÒâʵÑéÑо¿Êý¾ÝºÍδ¾­ÔÞ³ÉʹÓÃËûÈËÊðÃûÎÊÌ⣬£¬ÇҺؾÛÁ¼½«¸ÃÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨Åú×¼ºÅ82160793£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®¶þÌõµÚ¶þÏî¡¢µÚËÄÊ®ÈýÌõµÚÒ»Ï£¬×÷·ÏºØ¾ÛÁ¼¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°¼ä³äÖʸÉϸ°ûȪԴÍâÃÚÌåת´ïLINC00957°ÐÏòµ÷¿ØWT1Ó°Ïì¹ÇѪÁöϸ°û×ÔÊɼ°×³Ò©¼¦ÑªÌÙÌáÈ¡µ¥ÌåëÈïÒì»ÆÍªµÄ¸ÉÔ¤»úÖÆÑо¿¡±£¨Åú×¼ºÅ82160793£©£¬£¬×·»ØÒѲ¦×ʽ𣬣¬×÷·ÏºØ¾ÛÁ¼¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèºØ¾ÛÁ¼×ª´ïÆ·ÆÀ¡£

£¨¶þ£©¾­²é£¬£¬¼ªÁÖijҽԺÀîÔóµÈ½ÒÏþµÄÂÛÎÄ¡°Ze Li*, et al. Long Non-Coding RNA C1QTNF1 Antisense RNA 1 Upregulates Hexokinase 2 by Sponging microRNA-484 to Promote the Malignancy of Colorectal Cancer. Cancer Manag Res, 2020, 12:12053-12066.¡±±£´æÉúÒâʵÑéÑо¿Êý¾ÝÎÊÌ⣬£¬ÇÒÀîÔ󽫸ÃÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨ÉêÇëºÅ8217114340£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®¶þÌõµÚ¶þÏ£¬×÷·ÏÀîÔó¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÀîÔóת´ïÆ·ÆÀ¡£

£¨Èý£©¾­²é£¬£¬ºþÄÏij¸ßУÂíãüµÈ½ÒÏþµÄÂÛÎÄ¡°Hong Ma*, et al. Long Noncoding RNA LINC00525 Promotes the Aggressive Phenotype of Chordoma Through Acting as a microRNA-505-3p Sponge and Consequently Raising HMGB1 Expression. Onco Targets Ther, 2020, 13:9015-9027.¡±±£´æÉúÒâʵÑéÑо¿Êý¾ÝÎÊÌ⣬£¬ÇÒÂíãü½«¸ÃÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨ÉêÇëºÅ8210115144£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®¶þÌõµÚ¶þÏ£¬×÷·ÏÂíãü¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÂíãüת´ïÆ·ÆÀ¡£

£¨ËÄ£©¾­²é£¬£¬¹ã¶«Ä³¸ßУÑîÒ«¡¢Íõ½ø½øÓëÀîÎÄÑåµÈ½ÒÏþµÄÂÛÎÄ1¡°Yao Yang#, Jinjin Wang, Wenyan Li, et al.. Enhanced biofiltration coupled with ultrafiltration process in marine recirculating aquaculture system: Fast start-up of nitrification and long-term performance. Separation and Purification Technology, 2024, 335, 125795£¨±ê×¢»ù½ðºÅ42077131¡¢41977126£©¡±±£´æÉúÒâÂÛÎÄ¡¢Î´¾­ÔÞ³ÉʹÓÃËûÈËÊðÃû¡¢Ë½×Ô±ê×¢ËûÈË¿ÆÑ§»ù½ðÏîÄ¿ÎÊÌ⣻ÂÛÎÄ2¡°Yao Yang, Jinjin Wang, Wenyan Li*, et al.Biological activated carbon filtration controls membrane fouling and reduces by-products from chemically enhanced backwashing during ultrafiltration treatment. Water, 2023, 15£¨21£©, 3803.£¨±ê×¢»ù½ðºÅ41977126¡¢42077131£©¡±±£´æÉúÒâÂÛÎÄ¡¢ÔÚÓë¿ÆÑ§»ù½ðÏîÄ¿Î޹صĿÆÑÐЧ¹ûÖбê×¢»ù½ðÏîÄ¿µÄÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®¶þÌõµÚ¶þÏî¡¢µÚËÄÊ®ÈýÌõµÚÒ»ÏîºÍµÚÁùÏ£¬×÷·ÏÑîÒ«¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ5Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2029Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÑîҫת´ïÆ·ÆÀ£»ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®¶þÌõµÚ¶þÏî¡¢µÚËÄÊ®ÈýÌõµÚËÄÏîºÍµÚ°ËÏîµÄ»®¶¨£¬£¬×÷·ÏÍõ½ø½ø¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÍõ½ø½ø×ª´ïÆ·ÆÀ£»ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®¶þÌõµÚ¶þÏî¡¢µÚËÄÊ®ÈýÌõµÚËÄÏîºÍµÚ°ËÏ£¬×÷·ÏÀîÎÄÑå¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÀîÎÄÑåת´ïÆ·ÆÀ¡£

£¨Î壩¾­²é£¬£¬½­Î÷ij¸ßУÖÓÎĺÍÔ¸£²ÆµÈ½ÒÏþµÄÂÛÎÄ¡°Wen Zhong, Fucai Yue*, et al. Fractal Behavior of Particle Size Distribution in the Rare Earth Tailings Crushing Process under High Stress Condition. Applied Sciences 2018, 8: 1058.£¨±ê×¢»ù½ðºÅ51504102¡¢51764014¡¢51404111£©¡±±£´æØâÇÔØâÇÔ¡¢Î±Ôì¸Ä¶¯¡¢Î´¾­ÔÞ³ÉʹÓÃËûÈËÊðÃû¡¢Ë½×Ô±ê×¢ËûÈË»ù½ðÏîÄ¿ÎÊÌ⣬£¬ÇÒÖÓÎĽ«ÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨Åú×¼ºÅ52364014£©ÉêÇëÊé¡¢ÁÐÈë»ù½ðÏîÄ¿£¨Åú×¼ºÅ51764014£©Ï£Íû±¨¸æ¼°»ù½ðÏîÄ¿£¨Åú×¼ºÅ51504102¡¢51764014£©½áÌⱨ¸æ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®ÆßÌõ£¬£¬µÚËÄÊ®Ìõ£¬£¬µÚËÄÊ®ÈýÌõµÚÒ»ÏîºÍµÚÁùÏ£¬µÚËÄÊ®ÁùÌõ£¬£¬×÷·ÏÖÓÎĹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°Àë×ÓÐÍÏ¡ÍÁβ¿ó±ßÆÂÖÎÀídz²ãÖ²±»¸ùϵ¹ÌÍÁÁ¦Ñ§ÐÐΪÑо¿¡±£¨Åú×¼ºÅ52364014£©¡¢¡°½þ¿óÇÖÊ´×÷ÓÃÏÂÀë×ÓÐÍÏ¡ÍÁ¿ó´²»ùÑÒºêϸ¹ÛÁÓ»¯»úÖÆÑо¿¡±£¨Åú×¼ºÅ51764014£©¡¢¡°Ô­µØ½þ¿óºóÀë×ÓÐÍÏ¡ÍÁ¿óÌå΢½á¹¹Á¦Ñ§ÌØÕ÷Èõ»¯»úÖÆÑо¿¡±£¨Åú×¼ºÅ51504102£©£¬£¬×·»Ø3¸öÏîÄ¿µÄÒѲ¦×ʽ𣬣¬×÷·ÏÖÓÎĹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÖÓÎÄת´ïÆ·ÆÀ£»ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®ÆßÌõ£¬£¬µÚËÄÊ®Ìõ£¬£¬µÚËÄÊ®ÈýÌõµÚÒ»ÏîºÍµÚÁùÏ£¬×÷·ÏÔ¸£²Æ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ5Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2029Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÔ¸£²Æ×ª´ïÆ·ÆÀ¡£

£¨Áù£©¾­²é£¬£¬¹ã¶«Ä³¸ßУ»Æ¹ÚȺµÈ½ÒÏþµÄÂÛÎÄ1¡° Guanqun Huang#, et al. Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p. J Exp Clin Cancer Res.2018 Jul 25;37(1):169.£¨±ê×¢»ù½ðºÅ81673206£©¡±±£´æÉúÒâʵÑéÑо¿Êý¾ÝÎÊÌ⣬£¬ÂÛÎÄ2¡°Guanqun Huang#, et al. LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner. J Exp Clin Cancer Res. 2018 Jun 20;37(1):121.£¨±ê×¢»ù½ðºÅ81673206£©¡±±£´æÍ¼Æ¬Ê¹ÓÃÔÓÂÒÎÊÌ⣻ÂÛÎÄ1¡¢2»¹±£´æÎ´¾­ÔÞ³ÉʹÓöàÈËÊðÃû¡¢Ë½×Ô±ê×¢»ù½ðÏîÄ¿×ÊÖúµÈÎÊÌ⣬£¬ÇһƹÚȺ½«ÂÛÎÄ1ºÍÂÛÎÄ2ÁÐÈë»ù½ðÏîÄ¿£¨ÉêÇëºÅ8197110308¡¢8207110324£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®ÆßÌõ£¬£¬µÚËÄÊ®Ìõ£¬£¬µÚËÄÊ®¶þÌõµÚ¶þÏî¡¢µÚÎåÏ£¬µÚËÄÊ®ÈýÌõµÚÒ»Ïî¡¢µÚÁùÏ£¬×÷·Ï»Æ¹ÚȺ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ5Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2029Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓè»Æ¹ÚȺת´ïÆ·ÆÀ¡£

£¨Æß£©¾­²é£¬£¬ÉϺ£Ä³¸ßУÑà¶«ÁÁµÈ½ÒÏþµÄÂÛÎÄ¡°Dongliang Yan*, et al. FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of ¦Â-catenin. Experimental & molecular medicine, 2018.50(12), 1¨C12.¡±±£´æÉúÒâʵÑéÑо¿Êý¾ÝÎÊÌ⣬£¬ÇÒÑà¶«ÁÁ½«¸ÃÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨ÉêÇëºÅ8197101420£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®¶þÌõµÚ¶þÏ£¬×÷·ÏÑà¶«ÁÁ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÑà¶«ÁÁת´ïÆ·ÆÀ¡£

£¨°Ë£©¾­²é£¬£¬ºþ±±Ä³¸ßУÓàÖ¾ºìµÈ½ÒÏþµÄÂÛÎÄ¡°Zhihong Yu*, et al. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer. Int J Nanomedicine. 2017;12:6153-6168.£¨±ê×¢»ù½ðºÅ81402434£©¡±ºÍ¡°Zhihong Yu*, et al. Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance. Oncotarget.2017, 8:111281-11294.¡±±£´æÍ¼Æ¬Î±Ôì¸Ä¶¯ºÍδ¾­ÔÞ³ÉʹÓÃËûÈËÊðÃûÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®Ìõ¡¢µÚËÄÊ®ÈýÌõµÚÒ»Ï£¬×÷·ÏÓàÖ¾ºì¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÓàÖ¾ºìת´ïÆ·ÆÀ¡£

£¨¾Å£©¾­²é£¬£¬Õ㽭ijÁ½Ëù¸ßУÐì¼Ì¡¢ËιãÔªµÈ½ÒÏþµÄÂÛÎÄ¡°Guangyuan Song#, Ji Xu*, et al. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression. Oncotarget. 2017, 8(28):45725-45735.¡±±£´æÍ¼Æ¬Î±Ôì¸Ä¶¯ÎÊÌ⣬£¬ÇÒÐì¼Ì½«¸ÃÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨ÉêÇëºÅ8180110074¡¢8207101224£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®Ìõ£¬£¬×÷·ÏÐì¼Ì¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÐì¼Ìת´ïÆ·ÆÀ£»ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®Ìõ£¬£¬×÷·ÏËιãÔª¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèËιãԪת´ïÆ·ÆÀ¡£

£¨Ê®£©¾­²é£¬£¬ÁÉÄþij¸ßУ·½¾§¾§ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈݺÍÌṩÐéαÙÉÐÐר¼ÒÍÆ¼öÐÅÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ¡¢µÚËÄʮһÌõµÚÈýÏ£¬×÷·Ï·½¾§¾§2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°»ùÓÚÈýάÉî¶ÈѧϰÊÖÒÕµÄÓñÃ×ȺÌåÐÎ̬½á¹¹ÆÊÎöÓëÈýÎ¬ÖØÐÞÒªÁìÑо¿¡±£¨ÉêÇëºÅ6247076473£©ÉêÇ룬£¬×÷·Ï·½¾§¾§¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ5Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2029Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓè·½¾§¾§×ª´ïÆ·ÆÀ¡£

£¨Ê®Ò»£©¾­²é£¬£¬ÉϺ£Ä³¸ßУÁº¾Þ²¨ÔÚ2023Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈݺͳö¾ß²»Êµ³ÂÊöÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ£¬£¬×÷·ÏÁº¾Þ²¨2023Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°ÐÂÐÍÃâÒß¼ì²éµãSiglec15ͨ¹ýµ÷¿ØËèÔ´ÒÖÖÆÏ¸°ûÔÚ×ÔÉíÃâÒßÐÔ¸ÎÑ×ÃâÒß΢ÇéÐεĻúÖÆÑо¿£¨ÉêÇëºÅ8230034806£©¡±ÉêÇ룬£¬×÷·ÏÁº¾Þ²¨¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇëÏîÄ¿×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÁº¾Þ²¨×ª´ïÆ·ÆÀ¡£

£¨Ê®¶þ£©¾­²é£¬£¬Ìì½òij¸ßУÕÅÄþÄþÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ£¬£¬×÷·ÏÕÅÄþÄþ2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°ÊàŦÈí¹ÇÐàÂõÓëÔÙÉúÐÞ¸´Õϰ­µÄ·Ö×Ó»úÖÆÑо¿¡±£¨ÉêÇëºÅ8240092759£©ÉêÇ룬£¬×÷·ÏÕÅÄþÄþ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÕÅÄþÄþת´ïÆ·ÆÀ¡£

£¨Ê®Èý£©¾­²é£¬£¬½­ËÕij¸ßУ²Ü¶¶ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ£¬£¬×÷·Ï²Ü¶¶2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°ÔËÓÃÂѰ×ÖÊ×éѧ̽ÌÖÌæÄªßò°·ÖÎÁÆÄÍÊÜÓ뽺ÖÊÁöÖÐС½ºÖÊϸ°ûµÄ¹ØÏµ¡±£¨ÉêÇëºÅ8240131039£©ÉêÇ룬£¬×÷·Ï²Ü¶¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓè²Ü¶¶ת´ïÆ·ÆÀ¡£

£¨Ê®ËÄ£©¾­²é£¬£¬ºÚÁú½­Ä³¸ßУËïç÷ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ£¬£¬×÷·ÏËïç÷2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°IL-33µ÷¿ØÐ¡½ºÖÊϸ°ûºÍ¾ÞÊÉϸ°û¶Ô¼¹ËèËðÉ˺óËèÇÊÔÙÉúµÄ×÷ÓÃÑо¿¡±£¨ÉêÇëºÅ8240055211£©ÉêÇ룬£¬×÷·ÏËïç÷¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèËïç÷ת´ïÆ·ÆÀ¡£

£¨Ê®Î壩¾­²é£¬£¬½­ËÕij¸ßУÍõ³¿¾¸ÔÚ2023Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ£¬£¬×÷·ÏÍõ³¿¾¸2023Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°STT3a½éµ¼µÄϸ°ûÖ¬ÖʺϳÉÔڽ᳦°©Î÷Í×Îôµ¥¿¹ÄÍÒ©ÖеÄ×÷Óü°Æä»úÖÆÑо¿¡±£¨ÉêÇëºÅ8230131444£©ÉêÇ룬£¬×÷·ÏÍõ³¿¾¸¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÍõ³¿¾¸×ª´ïÆ·ÆÀ¡£

£¨Ê®Áù£©¾­²é£¬£¬ÉϺ£Ä³¸ßУÀî»ÂÕéÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ£¬£¬×÷·ÏÀî»ÂÕé2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°»ùÓÚÉî¶ÈѧϰµÄ¿ÚÇ»ÎÀÉúÖ¸µ¼Æ½Ì¨µÄÒªº¦ÊÖÒÕÑо¿¡±£¨ÉêÇëºÅ8240031006£©ÉêÇ룬£¬×÷·ÏÀî»ÂÕé¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÀî»ÂÕéת´ïÆ·ÆÀ¡£

£¨Ê®Æß£©¾­²é£¬£¬±±¾©Ä³Ñо¿ÔºÓÐÏÞ¹«Ë¾Ì·ÇåÀ¤ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ£¬£¬×÷·ÏÌ·ÇåÀ¤2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°Ô°Çø×ÛºÏÄÜÔ´Ìå¶àÄÜЭͬÓÅ»¯Ä£×Ó¼°ÀûÒæÖ÷Ìå¼äЭµ÷¼¤Àø»úÖÆÑо¿¡±£¨ÉêÇëºÅ7247011904£©ÉêÇ룬£¬×÷·ÏÌ·ÇåÀ¤¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÌ·ÇåÀ¤×ª´ïÆ·ÆÀ¡£

£¨Ê®°Ë£©¾­²é£¬£¬É½¶«Ä³¸ßУÆë°®Ñ§ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ£¬£¬×÷·ÏÆë°®Ñ§2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°»ùÓÚ»ìãç±ßÑØµÄ¾Ö²¿ÓÐÔ´Òä×èÆ÷Éñ¾­Ôª¼°Æä¶¯Á¦Ñ§Ñо¿¡±£¨ÉêÇëºÅ6247013499£©ÉêÇ룬£¬×÷·ÏÆë°®Ñ§¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÆë°®Ñ§×ª´ïÆ·ÆÀ¡£

£¨Ê®¾Å£©¾­²é£¬£¬¹ã¶«Ä³¸ßÐ£ÌÆ½­²¨ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ£¬£¬×÷·ÏÌÆ½­²¨2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°·ÂÈË»úеÈËÌý¾õÑо¿¡±£¨ÉêÇëºÅ6247014292£©ÉêÇ룬£¬×÷·ÏÌÆ½­²¨¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÌÆ½­²¨×ª´ïÆ·ÆÀ¡£

£¨¶þÊ®£©¾­²é£¬£¬ËÄ´¨Ä³¸ßУÕÅÔ˾ÕÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ£¬£¬×÷·ÏÕÅÔ˾Õ2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°´óÆøÖÐCriegeeÖÐÐÄÌåÓëH2OºÍSO2·´Ó³µÄÀíÂÛÑо¿¡±£¨ÉêÇëºÅ4247050434£©ÉêÇ룬£¬×÷·ÏÕÅÔ˾չú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèÕÅÔ˾Õת´ïÆ·ÆÀ¡£

£¨¶þʮһ£©¾­²é£¬£¬ÁÉÄþij¸ßУËÎÏþÐñÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇëÀú³ÌÖб£´æØâÇÔËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪÊӲ촦Àí²½·¥¡·µÚËÄÊ®Ìõ£¬£¬×÷·ÏËÎÏþÐñ2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°»ùÓÚͼ½á¹¹¾ÛÀàÔöÁ¿µÄλÖÃ-Éç½»ÍøÂçȺÌåÅÌÎÊÒªº¦ÊÖÒÕÑо¿¡±£¨ÉêÇëºÅ6247072686£©ÉêÇ룬£¬×÷·ÏËÎÏþÐñ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ¼ÓÈëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬£¬¸øÓèËÎÏþÐñת´ïÆ·ÆÀ¡£

¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á½«³ÖÐø¶Ô¿ÆÑ§»ù½ðÏîÄ¿ÉêÇë¡¢ÆÀÉó¡¢Ö´Ðм°Ð§¹û½ÒÏþÀú³ÌÖб¬·¢µÄ¿ÆÑв»¶ËÐÐΪ¾ÙÐÐÑÏËà´¦Àí£¬£¬Çë¿í´ó¿Æ¼¼Ö°Ô±×Ô¾õ¼ùÐÐÐÂʱ´ú¿ÆÑ§¼Ò¾«Éñ£¬£¬¼á³ÖÓÅÒìµÄѧ·ç×÷·ç£¬£¬ã¡ÊØ¿ÆÑ§Æ·µÂ×¼Ôò£»Çë¸÷ÒÀÍе¥Î»×Ô¾õÍÆÐÐÒÀÍе¥Î»Ö÷ÌåÔðÈΣ¬£¬ÔöÇ¿¿ÆÑгÏÐŽ¨É裬£¬ÅäºÏ¹¹½¨ÓÅÒìµÄѧÊõÉú̬¡£

×ªÔØÈªÔ´£º£º¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»áÍøÕ¾

×ªÔØÈªÔ´ÉùÃ÷£º£º±¾ÎÄÕÂ×ªÔØ×Ô¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»áÍøÕ¾£¬£¬°æÈ¨¹éÔ­×÷Õß¼°Ô­ÍøÕ¾ËùÓС£±¾ÍøÕ¾²î³Ø×ªÔØÎÄÕµÄ׼ȷÐÔ¡¢Õýµ±ÐÔÈÏÕæ£¬£¬²éÔÄÈËÓ¦×ÔÐÐÅжÏÄÚÈÝÊÊÓÃÐÔ¡£×ªÔØ·ÇÉÌÒµÓÃ;£¬£¬ÈçȪԴ±ê×¢ÓÐÎó»òÇÖÕ¼ÄúµÄÈ¨Òæ£¬£¬ÇëÁªÏµÄϹ¬NG28¼¯ÍÅ´¦Àí£¬£¬ÎÒÃǽ«ÅäºÑþ³ØýÏà¹ØÄÚÈÝ¡£

 

Copyright ?°æÈ¨ËùÓУº£ºÄϹ¬NG28¼¯ÍÅÉÌѧԺ
µØµã£º£º¹ã¶«Ê¡Ñô½­Êн­³ÇÇøÂÞÇÙ·1ºÅ
ÔÁICP±¸06058882ºÅ
  • 111111111

    ÉÌѧԺÕÐÉú×ÉѯȺ

ÓÊÕþ±àÂ룺£º529500
ÓÊÏ䣺£ºgbs@gdou.edu.cn
¡¾ÍøÕ¾µØÍ¼¡¿